Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
40
NCT00854685
Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2009
Completion: Jan 31, 2010
NCT00928317
Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
Start: Apr 30, 2009
Completion: Dec 31, 2009
NCT03611985
Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
Phase: Phase 1/2
Role: Collaborator
Start: Mar 31, 2020
Completion: Mar 31, 2023